Neurognostics, Inc.
United StatesFDA applicant, unverified
- Devices
- 2
What Neurognostics, Inc. makes
Neurognostics, Inc. manufactures functional data acquisition devices, including the MINDSTATE FDAD (Functional Data Acquisition Device), designed for capturing and analyzing brain activity data. These devices are intended for clinical use in monitoring neurological function and supporting diagnostic assessments.
The company’s devices are classified as Class II under FDA regulations and are listed in the 510(k) clearance registry. The portfolio is regulated in the United States, where Neurognostics, Inc. is based.
Catalogue
- Regimes: 510(k) Registry: 510(k)
- Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Neurognostics, Inc. have in the registry?
The registry currently lists 2 devices for Neurognostics, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Neurognostics, Inc.'s devices?
Among its 2 most recently registered devices, Neurognostics, Inc. has devices listed in FDA 510(k) (2 devices).
What risk classes do Neurognostics, Inc.'s devices fall under?
Among its 2 most recently registered devices, the classes recorded for Neurognostics, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Neurognostics, Inc. in the registry?
The most recently registered devices listed for Neurognostics, Inc. include MINDSTATE FUNCTIONAL DATA ACQUISITION DEVICE, VERSION 1.0 and MINDSTATE FUNCTIONAL DATA ACQUISITION DEVICE (FDAD), VERSION 1.0.